Ameriprise’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $2.33M | Sell |
|
|||||
|
2024
Q4 | $3.8M | Buy |
|
|||||
|
2024
Q3 | $4.13M | Buy |
|
|||||
|
2024
Q2 | $3.78M | Buy |
|
|||||
|
2024
Q1 | $4.39M | Sell |
|
|||||
|
2023
Q4 | $7.51M | Buy |
|
|||||
|
2023
Q3 | $5.1M | Sell |
|
|||||
|
2023
Q2 | $5.44M | Sell |
|
|||||
|
2023
Q1 | $5.08M | Buy |
|
|||||
|
2022
Q4 | $4.09M | Sell |
|
|||||
|
2022
Q3 | $3.57M | Sell |
|
|||||
|
2022
Q2 | $4.43M | Buy |
|
|||||
|
2022
Q1 | $3.17M | Buy |
|
|||||
|
2021
Q4 | $3.59M | Buy |
|
|||||
|
2021
Q3 | $2.46M | Buy |
|
|||||
|
2021
Q2 | $1.98M | Sell |
|
|||||
|
2021
Q1 | $2.41M | Sell |
|
|||||
|
2020
Q4 | $5.91M | Buy |
|
|||||
|
2020
Q3 | $2.96M | Sell |
|
|||||
|
2020
Q2 | $4.17M | Sell |
|
|||||
|
2020
Q1 | $3.4M | Buy |
|
|||||
|
2019
Q4 | $2.05M | Sell |
|
|||||
|
2019
Q3 | $8.3M | Buy |
|
|||||
|
2019
Q2 | $12.4M | Buy |
|
|||||
|
2019
Q1 | $13.3M | Buy |
|
|||||
|
2018
Q4 | $9.3M | Sell |
|
|||||
|
2018
Q3 | $31.5M | Buy |
|
|||||
|
2018
Q2 | $40.6M | Buy |
|
|||||
|
2018
Q1 | $31.2M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $75K | Sell |
|
|||||
|
2016
Q2 | $66K | Sell |
|
|||||
|
2016
Q1 | $113K | Buy |
|
|||||
|
2015
Q4 | $118K | Sell |
|
|||||
|
2015
Q3 | $1.87M | Sell |
|
|||||
|
2015
Q2 | $2.82M | Buy |
|
|||||
|
2015
Q1 | $2.05M | Sell |
|
|||||
|
2014
Q4 | $1.96M | Buy |
|
|||||
|
2014
Q3 | $1.35M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $4K | Sell |
|
|||||
|
2013
Q2 | $4K | Buy |
|